FILTER RESULTS
FILTER RESULTS
close.svg

Showing 1 - 2 of 2

OPINION

Southeast Asia facing hidden extremist threat

Oped, Muhammad Makmun Rasyid, Published on 07/07/2025

» In May, Indonesia's counter-terrorism unit arrested an 18-year-old man in Gowa, South Sulawesi, on charges of spreading Islamic State (IS) propaganda and inciting bomb attacks on social media. Identified only as MAS, the suspect represents a deeply troubling development in Southeast Asia's struggle against terrorism: the rise of youth radicalisation driven entirely by online exposure.

OPINION

Unite to solve neglected diseases

Oped, Muhammad Radzi Abu Hassan, Published on 29/04/2025

» The successful collaboration between the health ministries of Malaysia and Thailand, industry partners in Egypt and Malaysia, and the Drugs for Neglected Diseases initiative (DNDi) to bring a new hepatitis C antiviral drug -- ravidasvir -- to market in 2022 was an important milestone. For years, a 12-week course of treatment using sofosbuvir cost between $70,000 (2.34 million baht) and $80,000, putting it out of reach for many in the Global South. But ravidasvir -- a safe and effective alternative when combined with sofosbuvir -- costs far less, averaging less than $500 per course.